Medicine Online
Any medical inquiries? Search MOL for answers:
NEWS
Home > News > 2006 > October > 13 > Test May Predict Liver Cancer Prognosis
Medical References
Diseases & Conditions
Women's Health
Mental Health
Men's Health
Healthy Choice News
Site Map Links
Medical Tips
Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news

Test May Predict Liver Cancer Prognosis

FRIDAY, Oct. 13 (HealthDay News) -- Measuring levels of cells that originate in bone marrow could help doctors predict outcomes for liver cancer patients, researchers say.

Patients with inoperable heptocellular carcinoma (HCC) had higher levels of "endothelial progenitor cells" (EPCs) -- precursors to the endothelial cells that line blood vessels -- compared to patients with liver tumors that could be treated surgically.

The study, by a team from the University of Hong Kong, included 80 patients with HCC, 16 patients with cirrhosis, and 14 healthy patients. The findings were published in the October issue of Hepatology.

The researchers say their study provides additional evidence that EPCs may play a role in liver tumor angiogenesis (the formation of new blood vessels).

Further research into the link between EPCs and liver cancer needs to be conducted, the study authors added. This line of investigation may lead to new treatments for HCC, an aggressive form of cancer that''s usually diagnosed at an advanced stage.

More information

The American Cancer Society has more about liver cancer.



-- Robert Preidt



SOURCE: Hepatology, news release, Oct. 3, 2006

Last Updated: Oct. 13, 2006

Copyright © 2006 ScoutNews LLC. All rights reserved.

HomeSitemap Contact UsAdvertisingPress RoomGive Us Your FeedbackRead Our Terms & Conditions and Our DisclaimerPrivacy Statement